Rezolute Depreciation & Amortization 2011-2025 | RZLT

Annual Depreciation & Amortization Rezolute

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
31 K	36 K	30 K	13 K	13 K	18 K	49 K	1.07 M	1.11 M	744 K	129 K	11.3 K	295	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.11 M	295	250 K

Quarterly Depreciation & Amortization Rezolute

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
8 K	-	-	-	8 K	-	-	-	10 K	-	-	-	3 K	10 K	-	-	4 K	7 K	-	-	3 K	6 K	3 K	-	5 K	9 K	5 K	12.7 K	27 K	38.8 K	267 K	267 K	267 K	533 K	267 K	278 K	268 K	278 K	268 K	150 K	70.3 K	150 K	70.3 K	30.5 K	27.7 K	57.9 K	27.4 K	886	886	1.77 K	886	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
533 K	886	93 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
AbbVie ABBV	764 M	$ 223.01	-0.99 %	$ 395 B	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Arbutus Biopharma Corporation ABUS	1.4 M	$ 4.68	1.85 %	$ 777 M	Canada
Aclaris Therapeutics ACRS	807 K	$ 3.38	3.21 %	$ 261 M	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	9.45 M	-	-15.15 %	$ 60.3 M	Britain
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Aptorum Group Limited APM	1.13 M	$ 1.33	-1.48 %	$ 7.25 M	China
Amphastar Pharmaceuticals AMPH	28.2 M	$ 25.76	0.19 %	$ 1.25 B	USA
Anika Therapeutics ANIK	6.43 M	$ 9.53	-1.19 %	$ 140 M	USA
Brickell Biotech BBI	41 K	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	172 M	-	0.49 %	$ 251 B	Cayman-islands
Biogen BIIB	673 M	$ 173.03	-2.55 %	$ 25.2 B	USA
BioVie BIVI	229 K	$ 1.54	-2.53 %	$ 2.28 M	USA
Bellicum Pharmaceuticals BLCM	11 K	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Aytu BioScience AYTU	5.38 M	$ 2.33	2.3 %	$ 14.6 M	USA
Arena Pharmaceuticals ARNA	3.87 M	-	-6.81 %	$ 3.04 B	USA
Baudax Bio BXRX	165 K	-	0.59 %	$ 63 K	USA
Catalyst Biosciences CBIO	1.07 M	$ 15.32	5.73 %	$ 1.01 B	USA
ChromaDex Corporation CDXC	663 K	-	-0.88 %	$ 598 M	USA
Axon Enterprise AXON	48.4 M	$ 586.28	3.15 %	$ 44.4 B	USA
Cerus Corporation CERS	1.86 M	$ 2.14	13.23 %	$ 395 M	USA
Caladrius Biosciences CLBS	174 K	-	-16.75 %	$ 25.8 M	USA
Celldex Therapeutics CLDX	3.18 M	$ 28.33	0.5 %	$ 1.82 M	USA
Cellectar Biosciences CLRB	192 K	$ 3.81	-5.35 %	$ 46.6 M	USA
Clovis Oncology CLVS	8.5 M	-	-7.23 %	$ 13 M	USA
Can-Fite BioPharma Ltd. CANF	14 K	$ 0.29	-5.01 %	$ 631 M	Israel
Cortexyme CRTX	322 K	-	-1.05 %	$ 67.1 M	USA
Benitec Biopharma BNTC	66 K	$ 12.91	0.78 %	$ 531 M	USA
Cytokinetics, Incorporated CYTK	9.53 M	$ 60.38	0.11 %	$ 6.76 M	USA
Deciphera Pharmaceuticals DCPH	2.1 M	-	-	$ 2.18 B	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	24.9 M	$ 11.55	8.86 %	$ 747 M	USA
Dynavax Technologies Corporation DVAX	4.63 M	$ 10.89	-0.09 %	$ 1.42 B	USA
Eloxx Pharmaceuticals ELOX	77 K	-	-5.68 %	$ 8.28 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA